Medical & Surgical Dermatology Center is categorized under Dermatologists in Tryon, NC and active since 2000.
Medical & Surgical Dermatology Center was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Peter Neinbach at the company’s single location by writing to 37 Wilderness Road, Tryon, North Carolina NC 28782 or by phoning (828) 859-6697. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical & Surgical Dermatology Center |
| Contact Person: | Peter Neinbach |
| Address: | 37 Wilderness Road, Tryon, North Carolina 28782 |
| Phone Number: | (828) 859-6697 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Dermatologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Medical & Surgical Dermatology Center was started in 2000 to provide professional Dermatologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Peter Neinbach for inquiries that concern Medical & Surgical Dermatology Center by calling the company number (828) 859-6697, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical & Surgical Dermatology Center can be found at the coordinates 35.220382,-82.239116 as well as the street address 37 Wilderness Road in Tryon, North Carolina 28782.
For its online presence, you may visit Medical & Surgical Dermatology Center’s website at and engage with its social media outlets through on Twitter and on Facebook.